4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000103
Chief Executive Officer sold 11,449 shares at $28.36 ($324,694)
- Chief Executive Officer acquired 25,528 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,528 | 25,528 | D | ||
| 2023-06-30 | Sale : show line 2 in the form 10b5-1 | −11,449 | $28.36 | $324,694 | 14,079 | D |
| Open-market sales · 11,449 sh · avg $28.36 · $324,694 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −25,528 | 144,655 | D |
Loading xslF345X04/wk-form4_1688155500.xml…